MicroRNA 375 modulates hyperglycemia-induced enteric glial cell apoptosis and Diabetes-induced gastrointestinal dysfunction by targeting Pdk1 and repressing PI3K/Akt pathway.
MicroRNA 375 modulates hyperglycemia-induced enteric glial cell apoptosis and Diabetes-induced gastrointestinal dysfunction by targeting Pdk1 and repressing PI3K/Akt pathway.
复制标题
MicroRNA 375 通过靶向 Pdk1 和抑制 PI3K/Akt 通路调节高血糖诱导的肠胶质细胞凋亡和糖尿病诱导的胃肠功能障碍
DOI:
10.1038/s41598-018-30714-0
复制
发表时间:
2018-08-23
影响因子:
4.6
通讯作者:
Gan H
中科院分区:
文献类型:
--
作者:
Chen Y;Liu G;He F;Zhang L;Yang K;Yu H;Zhou J;Gan H
Diabetic neuropathy can damage systemic nervous system, including alteration of enteric nervous system and subsequent gastrointestinal dysfunction. The effect of diabetes on enteric glia cell (EGC) is not clear. We investigated the effect of diabetes and hyperglycemia on EGC, and the role of microRNA375 in modulating EGC survival in vivo and in vitro. Streptozotocin-induced diabetic mice were intraperitoneally injected with microRNA375 inhibitor or its negative control. EGC was transfected with microRNA375 inhibitor or its mimic. Diabetes mice with gastrointestinal dysfunction showed increased apoptosis of EGC (no difference in cell numbers) and gene expression of micorRNA375 in the myenteric plexus. Hyperglycemia triggered apoptosis of EGC in vitro with decreased expression of Pdk1 and p-Akt, but increased expression of micorRNA375. MicorRNA375 mimic induced apoptosis of EGC in vitro with repressed Pdk1and p-Akt. MicorRNA375 inhibitor could both prevent hyperglycemia-induced apoptosis of EGC in vitro and diabetes-induced gastrointestinal dysfunction in vivo. Our results suggest that diabetes-induced gastrointestinal dysfunction is related to increased apoptosis of EGC in the myenteric plexus. Hyperglycemia can increase the expression of microRNA375 and damage EGC survival through PI3K/Akt pathway. MicroRNA375 specific inhibition can prevent hyperglycemia induced EGC damage and diabetes-induced gastrointestinal dysfunction.
登录
查看更多内容
DOI:
10.1007/s11938-017-0151-1
发表时间:
2017-12
期刊:
Current treatment options in gastroenterology
影响因子:
--
作者:
Piper MS;Saad RJ
通讯作者:
Saad RJ
DOI:
10.1146/annurev.pathol.4.110807.092222
发表时间:
2009
期刊:
Annual review of pathology
影响因子:
--
作者:
Lee YS;Dutta A
通讯作者:
Dutta A
影响因子:
1.4
作者:
Furlan, Maria Montserrat D.P.;Molinari, Sônia L.;Miranda Neto, Marcílio H. de
通讯作者:
Miranda Neto, Marcílio H. de
影响因子:
5.5
作者:
Baudry, Charlotte;Reichardt, Francois;Moriez, Raphael
通讯作者:
Moriez, Raphael
影响因子:
24.5
作者:
Bassotti, G;Villanacci, V;Salemi, B
通讯作者:
Salemi, B